Empirica Medical Company will take part in the 6th Annual Scientific and Practical Conference of the Ukrainian Association of Child Oncology and Hematology (UACOG), which will take place on February 13–14, 2026, in Kyiv.
The event will be held at American University Kyiv
(Poshtova Square, 3) and will bring together leading Ukrainian and international experts in the field of pediatric oncology and hematology.
About the Conference
The 6th UACOG Conference is an annual scientific and practical event with international participation, serving as an important professional platform for sharing clinical experience, discussing current challenges, and implementing modern approaches to the diagnosis, treatment, and monitoring of children with oncological and hematological diseases.
The conference is organized by the Ukrainian Association of Child Oncology and Hematology, a professional medical organization uniting specialists from across Ukraine around a common goal: the successful treatment of children with cancer in Ukraine.
Today, UACOG brings together over 100 oncologists, hematologists, nurses, surgeons, neurosurgeons, and researchers from 16 specialized centers across Ukraine, who work daily to protect the health of young patients.
Conference Goals and Focus
-
enhancing the professional level of specialists from all disciplines involved in the treatment of oncological and hematological diseases;
-
implementation of modern diagnostic, treatment, and patient monitoring methods;
-
development of international cooperation with профиль organizations;
-
legal support for association members, support for young professionals, and coordination with charitable organizations;
-
creating a space for open professional dialogue and interdisciplinary collaboration.
For Empirica Medical Company, participation in the 6th UACOG Conference is an important part of its systematic cooperation with the medical community and its support for initiatives aimed at advancing modern, evidence-based, and patient-centered medicine in Ukraine.
We value the opportunity to be part of a professional environment that shapes the future of pediatric oncology and hematology and remain open to expert dialogue, partnerships, and joint projects that have a tangible impact on the quality of medical care for children.